Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 15

Clinical Trial Report

TRC150094, a Novel Mitochondrial Modulator, Reduces Cardio-Metabolic Risk as an Add-On Treatment: a Phase-2, 24-Week, Multi-Center, Randomized, Double-Blind, Clinical Trial

       
Total article views   HTML views PDF downloads Totals
7,081 Dovepress* 6,704+ 392 7,096
PubMed Central* 377 116 493
Totals 7,081 508 7,589
*Since 25 February 2022
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed and Google Scholar